2026 H1 -tulosraportti
UUTTA
7 päivää sitten
‧45 min
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 77 | - | - | ||
| 100 | - | - | ||
| 1 521 | - | - | ||
| 95 | - | - | ||
| 75 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastot ja ETF:t, joilla on osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 H2 -tulosraportti 26.2.2027 |
| Menneet tapahtumat | ||
|---|---|---|
2026 H1 -tulosraportti 28.8. | ||
2025 H2 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 | ||
2024 H1 -tulosraportti 30.8.2024 |
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·11 t sittenKiinnitetty·Private placement and retail offering A private placement with a retail offering is ongoing. See stock exchange announcement here: https://newsweb.oslobors.no/message/681629 Nordnet customers can subscribe in the retail offering until 21:00 today. The price of the shares is unknown and will be set through the bookbuilding. One will therefore get the same price as in the private placement. Read more here: https://www.nordnet.no/emisjon/thor-medical-viktig-informasjon
·2 t sittenGreat stuff!! 🤩🤩🤩 🇳🇴 Norway → 🇺🇸 USA → patient 1. Herøya/AlphaOne continues to be upstream * Thor Medical produces and purifies the heavy/more stable isotopes, especially Th-228. * This is the part of the production that makes sense to centralize. * AlphaOne is now commercial and has already delivered the first customer order. 2. USA can get downstream production * Thor Medical can send material from Norway to the USA. * There, smaller, local production/processing units can handle the last part of the production, including the manufacturing of Pb-212. * The reason is that Pb-212 has a short lifespan, so it is a great advantage to produce it near the customers/patients instead of sending finished Pb-212 across the Atlantic. The CEO explicitly states that it would be natural to consider downstream production near the patients, especially in the USA. . Previously, the idea was more: AlphaOne → large AlphaTwo factory → AlphaGlobal AlphaTwo was previously described as a significant capacity expansion, with around USD 100 million in estimated investment and also a North American expansion. Now, management practically says: Why build one gigantic AlphaTwo in Norway if we can produce the raw material centrally and establish smaller downstream units near the markets? The CEO therefore describes AlphaTwo/AlphaGlobal more as a combination of upstream production in Norway + downstream production near the customers, rather than one monolithic factory.
·2 t sitten · MuokattuThe price will fall below kr 4.80. There will be volatility here now. Just take it easy. There will be good buys at lower prices going forward. This is not CRNA which traded for kr 190 mill today. kr 16 mill in turnover at Thor
- ·3 t sitten · MuokattuLatest news at midnight, see the picture. Congratulations to those who bought at 4,80kr. I will not speculate on what will happen with the price exactly tomorrow, but I have no doubt that this is a gigantic positive piece of news in the long run. For those of us who are in for a slightly longer horizon, this is golden news, while for those who were going in for a few days/weeks to skim the cream, I think it will be thin skimmed milk. Now it will be even more exciting until the report in February 🫣😇🥳🤩But, one must believe this means that AlphaOne gets a larger sales area, and then potentially sells out faster with USA downstream commercial infrastructure as they themselves say. Potentially this could mean that a decision about AlphaTwo is shifted towards us. I cannot see that this is bad news, the only bad news is that I didn't transfer money to my Nordnet account in time. Hereby send a big thank you to Nordea Bank which does not support Trustly.
·4 t sittenIs it allowed to hope for something like this tomorrow? 07:00 – "Thor Medical enters US partnership…" Now they have indeed said A, eagerly waiting for B 🫢🍿
It's not unthinkable, since everything went so smoothly and the issue was at 4.8. He who lives shall see.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Välittäjätilasto
Dataa ei löytynyt
2026 H1 -tulosraportti
UUTTA
7 päivää sitten
‧45 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·11 t sittenKiinnitetty·Private placement and retail offering A private placement with a retail offering is ongoing. See stock exchange announcement here: https://newsweb.oslobors.no/message/681629 Nordnet customers can subscribe in the retail offering until 21:00 today. The price of the shares is unknown and will be set through the bookbuilding. One will therefore get the same price as in the private placement. Read more here: https://www.nordnet.no/emisjon/thor-medical-viktig-informasjon
- ·2 t sittenGreat stuff!! 🤩🤩🤩 🇳🇴 Norway → 🇺🇸 USA → patient 1. Herøya/AlphaOne continues to be upstream * Thor Medical produces and purifies the heavy/more stable isotopes, especially Th-228. * This is the part of the production that makes sense to centralize. * AlphaOne is now commercial and has already delivered the first customer order. 2. USA can get downstream production * Thor Medical can send material from Norway to the USA. * There, smaller, local production/processing units can handle the last part of the production, including the manufacturing of Pb-212. * The reason is that Pb-212 has a short lifespan, so it is a great advantage to produce it near the customers/patients instead of sending finished Pb-212 across the Atlantic. The CEO explicitly states that it would be natural to consider downstream production near the patients, especially in the USA. . Previously, the idea was more: AlphaOne → large AlphaTwo factory → AlphaGlobal AlphaTwo was previously described as a significant capacity expansion, with around USD 100 million in estimated investment and also a North American expansion. Now, management practically says: Why build one gigantic AlphaTwo in Norway if we can produce the raw material centrally and establish smaller downstream units near the markets? The CEO therefore describes AlphaTwo/AlphaGlobal more as a combination of upstream production in Norway + downstream production near the customers, rather than one monolithic factory.
- ·2 t sitten · MuokattuThe price will fall below kr 4.80. There will be volatility here now. Just take it easy. There will be good buys at lower prices going forward. This is not CRNA which traded for kr 190 mill today. kr 16 mill in turnover at Thor
- ·3 t sitten · MuokattuLatest news at midnight, see the picture. Congratulations to those who bought at 4,80kr. I will not speculate on what will happen with the price exactly tomorrow, but I have no doubt that this is a gigantic positive piece of news in the long run. For those of us who are in for a slightly longer horizon, this is golden news, while for those who were going in for a few days/weeks to skim the cream, I think it will be thin skimmed milk. Now it will be even more exciting until the report in February 🫣😇🥳🤩But, one must believe this means that AlphaOne gets a larger sales area, and then potentially sells out faster with USA downstream commercial infrastructure as they themselves say. Potentially this could mean that a decision about AlphaTwo is shifted towards us. I cannot see that this is bad news, the only bad news is that I didn't transfer money to my Nordnet account in time. Hereby send a big thank you to Nordea Bank which does not support Trustly.
- ·4 t sittenIs it allowed to hope for something like this tomorrow? 07:00 – "Thor Medical enters US partnership…" Now they have indeed said A, eagerly waiting for B 🫢🍿It's not unthinkable, since everything went so smoothly and the issue was at 4.8. He who lives shall see.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 77 | - | - | ||
| 100 | - | - | ||
| 1 521 | - | - | ||
| 95 | - | - | ||
| 75 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastot ja ETF:t, joilla on osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 H2 -tulosraportti 26.2.2027 |
| Menneet tapahtumat | ||
|---|---|---|
2026 H1 -tulosraportti 28.8. | ||
2025 H2 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 | ||
2024 H1 -tulosraportti 30.8.2024 |
Välittäjätilasto
Dataa ei löytynyt
2026 H1 -tulosraportti
UUTTA
7 päivää sitten
‧45 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 H2 -tulosraportti 26.2.2027 |
| Menneet tapahtumat | ||
|---|---|---|
2026 H1 -tulosraportti 28.8. | ||
2025 H2 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 | ||
2024 H1 -tulosraportti 30.8.2024 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·11 t sittenKiinnitetty·Private placement and retail offering A private placement with a retail offering is ongoing. See stock exchange announcement here: https://newsweb.oslobors.no/message/681629 Nordnet customers can subscribe in the retail offering until 21:00 today. The price of the shares is unknown and will be set through the bookbuilding. One will therefore get the same price as in the private placement. Read more here: https://www.nordnet.no/emisjon/thor-medical-viktig-informasjon
- ·2 t sittenGreat stuff!! 🤩🤩🤩 🇳🇴 Norway → 🇺🇸 USA → patient 1. Herøya/AlphaOne continues to be upstream * Thor Medical produces and purifies the heavy/more stable isotopes, especially Th-228. * This is the part of the production that makes sense to centralize. * AlphaOne is now commercial and has already delivered the first customer order. 2. USA can get downstream production * Thor Medical can send material from Norway to the USA. * There, smaller, local production/processing units can handle the last part of the production, including the manufacturing of Pb-212. * The reason is that Pb-212 has a short lifespan, so it is a great advantage to produce it near the customers/patients instead of sending finished Pb-212 across the Atlantic. The CEO explicitly states that it would be natural to consider downstream production near the patients, especially in the USA. . Previously, the idea was more: AlphaOne → large AlphaTwo factory → AlphaGlobal AlphaTwo was previously described as a significant capacity expansion, with around USD 100 million in estimated investment and also a North American expansion. Now, management practically says: Why build one gigantic AlphaTwo in Norway if we can produce the raw material centrally and establish smaller downstream units near the markets? The CEO therefore describes AlphaTwo/AlphaGlobal more as a combination of upstream production in Norway + downstream production near the customers, rather than one monolithic factory.
- ·2 t sitten · MuokattuThe price will fall below kr 4.80. There will be volatility here now. Just take it easy. There will be good buys at lower prices going forward. This is not CRNA which traded for kr 190 mill today. kr 16 mill in turnover at Thor
- ·3 t sitten · MuokattuLatest news at midnight, see the picture. Congratulations to those who bought at 4,80kr. I will not speculate on what will happen with the price exactly tomorrow, but I have no doubt that this is a gigantic positive piece of news in the long run. For those of us who are in for a slightly longer horizon, this is golden news, while for those who were going in for a few days/weeks to skim the cream, I think it will be thin skimmed milk. Now it will be even more exciting until the report in February 🫣😇🥳🤩But, one must believe this means that AlphaOne gets a larger sales area, and then potentially sells out faster with USA downstream commercial infrastructure as they themselves say. Potentially this could mean that a decision about AlphaTwo is shifted towards us. I cannot see that this is bad news, the only bad news is that I didn't transfer money to my Nordnet account in time. Hereby send a big thank you to Nordea Bank which does not support Trustly.
- ·4 t sittenIs it allowed to hope for something like this tomorrow? 07:00 – "Thor Medical enters US partnership…" Now they have indeed said A, eagerly waiting for B 🫢🍿It's not unthinkable, since everything went so smoothly and the issue was at 4.8. He who lives shall see.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 77 | - | - | ||
| 100 | - | - | ||
| 1 521 | - | - | ||
| 95 | - | - | ||
| 75 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastot ja ETF:t, joilla on osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Välittäjätilasto
Dataa ei löytynyt